Results

Total Results: 1,187 records

Showing results for "week".

81. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
    November 27, 2012 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … i.e., sleep adequacy, sleep quantity, sleep disturbance, and daytime somnolence) were observed at Week … There was a statistically significantly greater improvement in all domains of the MOS at Week 12 using … QoL) In Study XP052, improved RLSQoL scores, as assessed by the Johns Hopkins QoL Questionnaire, at week … However, at Week 12 using LOCF, there was an improvement in quality of life scores for all treatment

82. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - on the 2-week baseline bladder diary, and urge incontinence had to be the predominant Continual … months), with >2 associated symptoms (average of >7 micturitions/day, >7 episodes of urgency/week … , >1 urge incontinence episode/week necessitating change of clothing or pads). … with at least 7 urge incontinence episodes per week. … Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre

83. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - Layout 1 Background Preterm birth is defined as delivery before the completion of the 37th week of … Glossary Preterm birth: Delivery before completion of the 37th week of gestation.

84. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … NA CBD: 202.18 (SD 345.23) 12 week (3 months) Short A vs.

85. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … NA CBD: 202.18 (SD 345.23) 12 week (3 months) Short A vs.

86. Lumbar-Fusion-Draft-Report-Appendix-D (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
    January 01, 2019 - lidocaine 2% (0.5ml) and triamcinolone acetonide 40mg (0.5ml), "significant relief" for >=24 hours in week … tip received no current and remained at body temp NR NR Physical therapy (both groups) starting at week … B Any AE: 0% vs. 0% NR NR NR High 1 day 2 days 1 week 2 weeks 1 month 12 months Patient satisfaction … have alternative treatment (PT or surgery) if not responding or partially responding to tx after one week … fall resulting in spinal arthrodesis: 3.2% (1/31) vs. 0% (0/29), RR NA NR NR University Moderate 1 week

87. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed- dose, randomized … Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week … A 13-week, multicenter, randomized, double- blind study of lumiracoxib in hip osteoarthritis. … Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, … Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double

88. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - than patients on mid-dose Qnexa.4,5 In 2011, Allison and colleagues announced results from a 56-week … to 2.1% in the placebo group (p<0.0001); in the ITT- LOCF analysis, LS mean percent weight loss at week … The majority of these events were reported as abdominal pain and nausea during the first week after … implantation; however, 23% of patients were reported to have vomiting during the first week after … patients in whom EndoBarrier was successfully implanted, 8 terminated treatment before the full 12-week

89. Microsoft Word - Comp Eff 10.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - - For heart failure patients, an initial dose of 5 mg can be increased over a several-week period … literature describing direct comparisons of ACEIs versus ARBs we searched: • MEDLINE® (1966 to May Week … One of the larger studies in this group (n = 190) reported a greater short-term increase (12-week study … out of 192 patients treated with losartan developed an increase in serum creatinine during the 12-week … A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension

90. Updating the Framework for Agency for Healthcare Research and Quality’s National Healthcare Quality and Disparities Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-disposition-comments.pdf
    July 11, 2025 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

91. Disposition of Comments_Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-disposition-comments.pdf
    May 01, 2025 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

92. Disposition of Comments: Technical Brief No. 51_Measure Criteria for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/measurement-criteria-qdr-disposition-comments.pdf
    April 11, 2025 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

93. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
    December 16, 2011 - Evidence-based Practice Center Systematic Review Protocol 1 Source: www.effectivehealthcare.ahrq.gov Published Online: December 16, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening and Diagnosis of Gestational Diabetes Mellitus I. Background and Objectives for th…

94. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - With two 24-48-week statin-ezetimibe trials of 971 participants, the rate of incident cancer was 1 percent … We searched Ovid MEDLINE® from August Week 1, 2008, to May Week 5, 2009, and EMBASE from Week 30, 2008 … , to Week 23, 2009. … In this 56-week trial of 100 participants of mostly European descent with established carotid artery

95. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - The regimens evaluated included once-daily or on-demand dosing; a regimen of 4-week PPI therapy with … Frequent heartburn is defined as heartburn that occurs 2 or more days per week.

96. PEPTIC ULCER #11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - of adverse reactions in subjects with SBS participating in two randomized, placebo-controlled, 24-week … obstruction.7 3 In a phase III randomized controlled trial with an open-label extension, at week … weeks of treatment, 54% of patients treated with teduglutide reduced the number of infusion days per week … and 24% of patients reduced their infusion days per week by 3 or more days. … The mean reduction in PN volume and/or intravenous fluids was 5.2 liters per week from pretreatment

97. PEPTIC ULCER #11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
    January 01, 2012 - Patients with severe UC report paying $300 to $4,700 for a 10-week dose of pig whipworms ordered from … for three vials, plus shipping. 4 Patients with severe UC report paying $300 to $4,700 for a 10-week … Clinical Colitis Activity Index to 57% of baseline, and no adverse events were seen during the 28-week … /or intravenous fluid volumes) versus 30% of patients (n = 43) given placebo (p = 0.002). 28 At week … , and 24% of patients reduced their infusion days per week by 3 or more days.

98. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - ; 1 week to <2 weeks; 2 weeks to 4 weeks? … satisfaction, and quality of life after followup at the following intervals: <1 day; 1 day to <1 week … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … Search Strategy Ovid Database(s): APA PsycInfo 1806 to December Week 4 2021, EBM Reviews - Cochrane

99. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain Evidence Summary Main …

100. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - In all three studies, blood Phe decreased after 1 week of treatment but remained above clinically … Period: NR Funding: NR Disclosures: NR Design: RCT Alternating placebo or sapropterin 1 week … at a time, beginning with a week on sapropterin or placebo Inclusion Criteria: PKU diagnosis, age … In all three studies, blood Phe decreased after 1 week of treatment but remained above clinically